Stonebrook Private Inc. Tango Therapeutics, Inc. Transaction History
Stonebrook Private Inc.
- $382 Billion
- Q4 2024
A detailed history of Stonebrook Private Inc. transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Stonebrook Private Inc. holds 10,992 shares of TNGX stock, worth $25,831. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,992Holding current value
$25,831% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding TNGX
# of Institutions
138Shares Held
91.1MCall Options Held
1.4KPut Options Held
4.4K-
Trv Gp Iv, LLC Boston, MA16.9MShares$39.6 Million64.97% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA10.7MShares$25.2 Million5.42% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$25 Million1.53% of portfolio
-
Nextech Invest Ag5.53MShares$13 Million3.19% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4MShares$9.4 Million0.07% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $207M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...